Basics Candel Therapeutics, Inc. Common Stock IPO Date: July 27, 2021 Sector: Healthcare Industry: Biotech Market Cap: $292.61M Activated in VL: True Average Daily Range Avg Daily Range: $0.23 | 4.88% Avg Daily Range (30 D): $0.13 | 2.59% Avg Daily Range (90 D): $0.16 | 2.89% Institutional Daily Volume Avg Daily Volume: .7M Avg Daily Volume (30 D): .65M Avg Daily Volume (90 D): .68M Trade Size Avg Trade Size (Sh.): 148 Avg Trade Size (Sh.) (30 D): 122 Avg Trade Size (Sh.) (90 D): 121 Institutional Trades Total Inst.Trades: 108 Avg Inst. Trade: $1.42M Avg Inst. Trade (30 D): $1.07M Avg Inst. Trade (90 D): $1.16M Avg Inst. Trade Volume: .19M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.11M Avg Closing Trade (30 D): $1.04M Avg Closing Trade (90 D): $1.04M Avg Closing Volume: 307.63K     News Nov 4, 2025 @ 2:00 PM Candel Therapeutics Showcases Immunotherapy Leader... Source: Candel Therapeutics Apr 1, 2025 @ 12:01 PM Candel Therapeutics Announces Publication of Phase... Source: N/A Mar 18, 2025 @ 12:00 PM Candel Therapeutics Appoints Renowned Pancreatic C... Source: N/A Dec 12, 2024 @ 9:51 PM Candel Therapeutics Announces $80 Million Proposed... Source: N/A Sep 4, 2024 @ 12:00 PM Milestone Pharmaceuticals Appoints Industry Vetera... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.21 $-.09 Diluted EPS $-.21 $-.09 Revenue $ $ M $ M Gross Profit $ $ $ Net Income / Loss $ $ -11.27M $ -4.8M Operating Income / Loss $ $ -13.21M $ -11.18M Cost of Revenue $ $ $ Net Cash Flow $ $ -13.72M $ 8.52M PE Ratio